Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Sanofi-Aventis |
---|---|
Information provided by: | Sanofi-Aventis |
ClinicalTrials.gov Identifier: | NCT00094081 |
The trial will compare the efficacy and safety of concomitant chemoradiation with tirapazamine, cisplatin and radiation versus cisplatin and radiation.
Condition | Intervention | Phase |
---|---|---|
Head and Neck Neoplasms |
Drug: tirapazamine (SR259075) Drug: cisplatin Procedure: Radiation Therapy |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Phase III Randomized Trial of Concomitant Radiation, Cisplatin, and Tirapazamine Versus Concomitant Radiation and Cisplatin in Patients With Advanced Head and Neck Cancer |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Arizona | |
Foundation for Cancer Research and Education | |
Phoenix, Arizona, United States, 85013 | |
United States, California | |
Stanford University Medical Center | |
Palo Alto, California, United States, 94305 | |
United States, Florida | |
H-Lee Moffitt Cancer Center and Research | |
Tampa, Florida, United States, 33612 | |
United States, Illinois | |
University of Chicago Medical Center | |
Chicago, Illinois, United States, 60637 | |
United States, Maryland | |
Johns Hopkins Hospital | |
Baltimore, Maryland, United States, 21231 | |
United States, Michigan | |
Harper Hospital | |
Detroit, Michigan, United States, 48201 | |
United States, New Jersey | |
VA New Jersey Health Care Medical Center | |
East Orange, New Jersey, United States, 07018 | |
United States, New York | |
University of Rochester Medical Center | |
Rochester, New York, United States, 14620 | |
United States, South Carolina | |
Medical University of South Carolina | |
Charleston, South Carolina, United States, 29425 | |
United States, Virginia | |
Eastern Virginia Medical School | |
Norfolk, Virginia, United States, 23507 |
Study Director: | ICD CSD | Sanofi-Aventis |
Responsible Party: | sanofi-aventis ( ICD Study Director ) |
Study ID Numbers: | EFC4690, SR259075 |
Study First Received: | October 11, 2004 |
Last Updated: | August 20, 2008 |
ClinicalTrials.gov Identifier: | NCT00094081 |
Health Authority: | United States: Food and Drug Administration |
squamous cell carcinoma oropharynx oral cavity larynx hypopharynx |
Epidermoid carcinoma Cisplatin Squamous cell carcinoma Head and Neck Neoplasms |
Carcinoma, squamous cell Tirapazamine Carcinoma, Squamous Cell Carcinoma |
Neoplasms Neoplasms by Site Radiation-Sensitizing Agents Antineoplastic Agents |
Therapeutic Uses Physiological Effects of Drugs Pharmacologic Actions |